Peptide library

Synthetic peptide fragment studied mainly in rodent models of tendon, gut and soft-tissue injury.

Blend of a GHRH analog and a ghrelin-receptor agonist, marketed to raise growth hormone.

Neuropeptide first isolated in the 1970s and studied for sleep regulation.

Copper-binding tripeptide used in topical cosmetics and studied for skin remodeling.

GLP-1 receptor agonist with large human trials in type 2 diabetes and chronic weight management.

Dual GIP/GLP-1 receptor agonist studied in type 2 diabetes and chronic weight management.

Long-acting IGF-1 analog used mainly in cell-culture research.

Marketed blend reportedly combining KPV, BPC-157, TB-500 and GHK-Cu. Exact contents vary by seller.

Human antimicrobial peptide studied in lab and early clinical settings.

Mitochondria-derived peptide studied in animal models of metabolism and exercise.

Melanocortin receptor agonist studied for hypoactive sexual desire disorder (HSDD).

Synthetic peptides developed in Russia and studied for cognitive and anxiety-related effects.

GHRH(1-29) analog historically marketed for pediatric growth hormone deficiency.

Synthetic fragment related to thymosin beta-4, studied in animal and lab models of wound healing.

Synthetic GHRH analog studied for reducing excess abdominal fat in people with HIV-associated lipodystrophy.

Thymic peptide approved in several countries outside the U.S. for hepatitis B and as an immune adjuvant.

Marketed blend usually combining BPC-157 and TB-500. Exact contents vary by seller.